Come up with a name for your new list and we'll add to it:
Promedior raised a round of funding on July 23, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Promedior is a clinical stage immunotherapy company pioneering the development of targeted therapeutics to treat diseases involving fibrosis. Fibrosis occurs when healthy tissue is replaced with exces…